Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Amortizatization of Intangibles (2016 - 2025)

Cardiff Oncology's Amortizatization of Intangibles history spans 11 years, with the latest figure at -$150000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 251.52% year-over-year to -$150000.0; the TTM value through Dec 2025 reached $540000.0, changed 0.19%, while the annual FY2025 figure was $540000.0, 0.19% changed from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was -$150000.0 at Cardiff Oncology, down from $420000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $420000.0 in Q3 2025 and bottomed at -$494000.0 in Q2 2021.
  • The 5-year median for Amortizatization of Intangibles is $113000.0 (2024), against an average of -$11950.0.
  • The largest annual shift saw Amortizatization of Intangibles soared 412.5% in 2023 before it plummeted 251.52% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$447000.0 in 2021, then skyrocketed by 108.95% to $40000.0 in 2022, then skyrocketed by 412.5% to $205000.0 in 2023, then plummeted by 51.71% to $99000.0 in 2024, then tumbled by 251.52% to -$150000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Amortizatization of Intangibles are -$150000.0 (Q4 2025), $420000.0 (Q3 2025), and $133000.0 (Q2 2025).